Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Genomic Profiling and Reducing Time to Non-small Cell Lung Cancer or Lymphoma Treatment Via Targeted Use of Endoscopic Ultrasound: a Randomized Clinical Trial on the Diagnostic Accuracy of Tissue Sampling With FNA Versus FNB

NCT06848738 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT06848738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06848738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Genomic Profiling and Reducing Time to Non-small Cell Lung Cancer or Lymphoma Treatment Via Targeted Use of Endoscopic Ultrasound: a Randomized Clinical Trial on the Diagnostic Accuracy of Tissue Sampling With FNA Versus FNB
Lead sponsor
Zealand University Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 7, 2024
Completion date
June 1, 2026
Enrollment
362 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lymphoma, sarcoidosis